BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35120599)

  • 1. New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening.
    Hackshaw A; Clarke CA; Hartman AR
    Cancer Cell; 2022 Feb; 40(2):109-113. PubMed ID: 35120599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
    Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
    Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cell-free DNA-based multi-cancer early detection.
    Zhang K; Fu R; Liu R; Su Z
    Trends Cancer; 2024 Feb; 10(2):161-174. PubMed ID: 37709615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
    Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
    Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
    Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
    Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
    Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
    Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cell-free DNA approaches for multi-cancer early detection.
    Jamshidi A; Liu MC; Klein EA; Venn O; Hubbell E; Beausang JF; Gross S; Melton C; Fields AP; Liu Q; Zhang N; Fung ET; Kurtzman KN; Amini H; Betts C; Civello D; Freese P; Calef R; Davydov K; Fayzullina S; Hou C; Jiang R; Jung B; Tang S; Demas V; Newman J; Sakarya O; Scott E; Shenoy A; Shojaee S; Steffen KK; Nicula V; Chien TC; Bagaria S; Hunkapiller N; Desai M; Dong Z; Richards DA; Yeatman TJ; Cohn AL; Thiel DD; Berry DA; Tummala MK; McIntyre K; Sekeres MA; Bryce A; Aravanis AM; Seiden MV; Swanton C
    Cancer Cell; 2022 Dec; 40(12):1537-1549.e12. PubMed ID: 36400018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
    Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
    EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 10. How to detect cancer early using cell-free DNA.
    Hasenleithner SO; Speicher MR
    Cancer Cell; 2022 Dec; 40(12):1464-1466. PubMed ID: 36513047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.
    Cree IA; Uttley L; Buckley Woods H; Kikuchi H; Reiman A; Harnan S; Whiteman BL; Philips ST; Messenger M; Cox A; Teare D; Sheils O; Shaw J;
    BMC Cancer; 2017 Oct; 17(1):697. PubMed ID: 29061138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.
    Bredno J; Venn O; Chen X; Freese P; Ofman JJ
    Am J Pathol; 2022 Oct; 192(10):1368-1378. PubMed ID: 35948080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
    Schmeising-Barnes N; Waller J; Marlow LAV
    Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and economic benefits associated with novel multi-cancer early detection tests: conference highlights from the 2022 ISPOR Annual Meeting.
    Nabavizadeh N
    Am J Manag Care; 2022 Aug; 28(7 Suppl):S123-S132. PubMed ID: 36067342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.
    Brito-Rocha T; Constâncio V; Henrique R; Jerónimo C
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for Oncologists.
    Post C; Braun TP; Etzioni R; Nabavizadeh N
    JCO Oncol Pract; 2023 Dec; 19(12):1111-1115. PubMed ID: 37851937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
    Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
    Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer.
    Keup C; Suryaprakash V; Hauch S; Storbeck M; Hahn P; Sprenger-Haussels M; Kolberg HC; Tewes M; Hoffmann O; Kimmig R; Kasimir-Bauer S
    Genome Med; 2021 May; 13(1):85. PubMed ID: 34001236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of recommendations and translational milestones for genomic tests in cancer.
    Chang CQ; Tingle SR; Filipski KK; Khoury MJ; Lam TK; Schully SD; Ioannidis JP
    Genet Med; 2015 Jun; 17(6):431-40. PubMed ID: 25341115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.